Game Changing Move? NFL Tackles Pain And Concussions In CBD Clinical Trial Partnership With Canadian University

Zinger Key Points
  • This Phase 1 trial marks a first step in exploring CBD's therapeutic potential for pain relief and neuroprotection from concussions.
  • 35 people will receive either a placebo or CBD-rich cannabis extract to test whether it’s safe and well-tolerated for daily use.

The NFL is teaming up with Canadian researchers to delve into the potential of cannabidiol (CBD) for pain management and neuroprotection from concussions, both significant concerns for its players. This Phase 1 trial marks a first step in exploring the non-intoxicating cannabinoid's therapeutic potential.

35 participants will test the safety and efficacy of CBD by receiving either a placebo or a cannabis extract enriched with the CBD compound, reported Cannabis Wire. Starting with a low dose of 5mg per kilogram of body weight, researchers from the University of Regina will gradually increase the amount to gauge optimal daily intake.

The study specifically aims to determine whether CBD, with its anti-inflammatory and neuroprotective properties, can be safely incorporated into players' off-season training routines, where intensive resistance exercises often lead to injuries, notes the University of Regina. Researchers will closely monitor the physiological and psychological effects of the varying doses, seeking to ensure the CBD's non-intoxicating nature and absence of adverse side effects.

How Common Are Concussions Among Football Players?

Brain injuries in football account for 65% to 95% of all fatalities, according to the Brain Injury Research Institute. Football injuries associated with the brain occur at the rate of one in every five-and-a-half games.

This venture represents another step in the NFL's growing commitment to CBD research. In 2022, the league pledged $1 million to fund this Canadian trial alongside another at the University of California San Diego, both focusing on CBD's potential as a pain management alternative to opioids for players suffering from concussions.

First Steps To Solving Serious Problem

While the Phase 1 trial is a small-scale initial step, its findings could pave the way for further research and, ultimately, wider acceptance of cannabis and CBD as a valuable tool in tackling the physical and mental challenges faced by professional athletes.

“I’ve long been an advocate of cannabis as a holistic way to help my body recover from the trauma it faced each day on the gridiron and knew there were many other ways to unleash the power of this plant into our daily lives,” said Calvin Johnson Jr., former Detroit Lions wide receiver and 2021 Pro Football Hall of Fame inductee. 

Photo: El Planteo

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsHealth CareMarketsGeneralCBDclinical trialnflUniversity of Regina
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.